N-alkyl-4-1(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]-benzamides, μ and δ opioid agonists:: a μ address

被引:5
作者
Carson, JR [1 ]
Coats, SJ [1 ]
Codd, EE [1 ]
Dax, SL [1 ]
Lee, J [1 ]
Martinez, RP [1 ]
McKown, LA [1 ]
Neilson, LA [1 ]
Pitis, PM [1 ]
Wu, WN [1 ]
Zhang, SP [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Drug Discovery, Spring House, PA 19477 USA
关键词
D O I
10.1016/j.bmcl.2004.02.052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The tertiary amide 6 opioid agonist 2 is a potent antinociceptive agent. Compound 2 was metabolized in vitro and in vivo to secondary amide 3, a potent and selective p opioid agonist. The SAR of a series of N-alkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylid-ene)phenylmethyl]benzamides was examined. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2113 / 2116
页数:4
相关论文
共 17 条
[1]   3-(αR)-α-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides:: Potent, non-peptidic agonists of both μ and δ opioid receptors [J].
Bishop, MJ ;
Garrido, DM ;
Boswell, GE ;
Collins, MA ;
Harris, PA ;
McNutt, RW ;
O'Neill, SJ ;
Wei, K ;
Chang, KJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) :623-633
[2]   Behavioral effects of δ-opioid receptor agonists:: Potential antidepressants? [J].
Broom, DC ;
Jutkiewicz, EM ;
Rice, KC ;
Traynor, JR ;
Woods, JH .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 90 (01) :1-6
[3]  
CALDERONE SN, 2001, FARMACO, V56, P117
[4]  
CARSON JR, 2001, Patent No. 0166543
[5]  
CARSON JR, 2004, BIOORG MED CHEM LETT, V14
[6]   Non-peptide delta opioid agonists and antagonists [J].
Dondio, G ;
Ronzoni, S ;
Petrillo, P .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) :1075-1098
[7]  
EDDY NB, 1953, J PHARMACOL EXP THER, V103, P74
[8]  
GLASS PSA, 1999, ANESTHESIOLOGY S, V91
[9]   MODULATION OF MU-MEDIATED ANTINOCICEPTION BY DELTA-AGONISTS IN THE MOUSE - SELECTIVE POTENTIATION OF MORPHINE AND NORMORPHINE BY [D-PEN2,D-PEN5]ENKEPHALIN [J].
HEYMAN, JS ;
VAUGHT, JL ;
MOSBERG, HI ;
HAASETH, RC ;
PORRECA, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (01) :1-10
[10]   Antiparkinson potential of δ-opioid receptor agonists [J].
Hudzik, TJ ;
Howell, A ;
Payza, K ;
Cross, AJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) :101-107